Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Research In The Bolivian Rainforest Suggests Ancient, Shared Roots Of Feeding Behaviours In Monkeys And Humans
Behavioural ecologists working in Bolivia have found that wild spider monkeys control their diets in a similar way to humans, contrary to what has been thought up to now. Rather than trying to maximize their daily energy intake, the monkeys tightly regulate their daily protein intake, so that it stays at the same level regardless of seasonal variation in the availability of different foods.
generic viagra online
N.D. Judge Vows To Act Quickly On Challenge To State Ultrasound Law
North Dakota Judge Douglas Herman failed to issue a temporary injunction on Thursday to prevent a state law from going into effect that requires abortion clinics to offer women the chance to view ultrasound images 24 hours prior to obtaining an abortion, the AP/Bismarck Tribune reports. Judge Herman promised to issue an opinion "as soon as possible" on the constitutional challenge to the state law, which is set to take effect on Aug. 1. The Center for Reproductive Rights filed the challenge, arguing that it creates an unnecessary burden on a woman"s right to an abortion.The group also said that a provision in the law is confusing and that the state"s only abortion provider is unsure how to comply. According to the AP/Tribune, the provision in question reads: "The auscultation of the fetal heart tone must be of a quality consistent with standard medical practice in the community." Suzanne Stolz, an attorney for CRR, said the bill"s language could require the Red River Women"s Clinic -- the only abortion clinic in the state -- to offer women the chance to hear audio of the fetal heartbeat in addition to the ultrasound image. She added that the clinic "cannot afford to guess what the law means and hope that it is right."Assistant Attorney General Douglas Bahr said that the law requires the clinic only to offer the option of an ultrasound, not provide one. He added that most people understand that an ultrasound includes both images and audio and that he does not "know why the clinic doesn"t feel it can offer this to the patient." Cass County state"s attorney Birch Burdick, a co-counsel with Bahr, said that although some of the language in the law is "a little confusing," he would not prosecute clinic officials if they make an attempt to apply the law until the judge rules.Tammi Kromenaker, the director of the clinic, said, "We"re disappointed that we did not get an injunction today but we felt that some of our questions were answered," adding that the clinics had offered women the option of viewing an ultrasound for the last 18 months (Kolpack, AP/Bismarck Tribune, 7/31).
News of the day
UCSF And Abbott Launch Viral Discovery Center At Mission Bay
The University of California, San Francisco, has partnered with Abbott, a global health care company, to launch a first-of-its kind, non-profit viral diagnostics center near the UCSF Mission Bay campus to help identify unknown viruses from around the world.
Health Insurance

Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for levonorgestrel tablets, 0.75 mg, for women seventeen years and younger. Levonorgestrel is the generic equivalent to Duramed Pharmaceuticals" PLAN B(R), which is indicated for the prevention of pregnancy following unprotected intercourse or contraceptive failure. This product is approved for prescription use only. The Company intends to market the product under the trade name Next Choice(TM) and plans to launch the product shortly. For the 12-months ending March 2009, PLAN B(R) had total U.S. sales of approximately $123 million, of which approximately ten percent are attributable to prescription sales, according to IMS sales data. PLAN B(R) over-the-counter (O.T.C.) new product exclusivity expires on August 24, 2009. About Watson Pharmaceuticals, Inc. Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women"s Health and Nephrology/Medical. Forward-Looking Statement Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson"s current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson"s current expectations depending upon a number of factors affecting Watson"s business. These factors include, among others, the impact of competitive products and pricing; market acceptance of and continued demand for Watson"s products; difficulties or delays in manufacturing; the difficulty of predicting the timing or outcome of FDA or other regulatory agency approvals or actions, if any; and other risks and uncertainties detailed in Watson"s periodic public filings with the Securities and Exchange Commission, including but not limited to Watson"s Annual Report on Form 10-K for the year ended December 31, 2008. PLAN B(R) is a registered trademark of Women"s Capital Corporation, a subsidiary of Duramed Pharmaceuticals, Inc. Watson Pharmaceuticals, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009